Supernus Pharmaceuticals (S49.STU) Q1 2026 Earnings

24FebConfirmed
Q1 2026
0.29
0.43
0.57
0.72

Details

Expected EPS
0.28866
Actual EPS
0.717848178
Surprise EPS
0.43
Surprise Percent
+148.68%

Description

Supernus Pharmaceuticals (S49.STU) has reported earnings of 0.717848178 per share for Q1 2026.

0 Comments

Share your thoughts